Metagil-GM2 Forte

Composition: Glimepiride 2 mg + Metformin 1000 mg (Sustained Release) bilayered

Metagil GM2 Forte is a high-strength combination of Glimepiride 2 mg and Metformin SR 1000 mg, intended for patients with significantly uncontrolled Type 2 Diabetes. It offers powerful glucose-lowering action by improving insulin release and reducing hepatic glucose output. The sustained-release mechanism ensures consistent sugar control with improved stomach tolerance.

Uses:

• Strong control of Type 2 Diabetes

• Reduction of fasting and post-meal sugar

• Effective HbA1c reduction

• Suitable for long-term diabetic management

Side Effects:

• Low blood sugar

• Dizziness, sweating

• GI discomfort

• Rare: lactic acidosis

Other Details:

• Must be taken with food

• Regular monitoring of sugar and kidney function is advised

• Not suitable for patients prone to hypoglycemia

Tags: Glimepiride 2 mg + Metformin 1000 mg (Sustained Release)